Status:
COMPLETED
Psychological Mechanisms of Behavioral Dysregulation
Lead Sponsor:
National Institute of Mental Health (NIMH)
Conditions:
Neural Systems
Psychopathology
Eligibility:
All Genders
20-50 years
Brief Summary
This study is directed toward a better understanding of how the brain regulates emotions and social and antisocial behavior. It will look at the use of the orbital frontal cortex and amygdala of the b...
Detailed Description
The Psychopathy Checklist-Revised (Hare, 1991) allows the identification of a relatively homogeneous population of individuals who present with marked emotional dysfunction (reduced empathy, guilt and...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Psychopathy:
- Comparison individuals: All individuals will score less than 20 on the PCL-R.
- Individuals with psychopathy: All individuals will score more than 30 on the PCL-R (participants scoring between 21-29 are excluded from study participation).
- Age: Participants will be males and females, 20-50 years of age.
- IQ: IQ, as measured by 4 subscales from the Wechsler Adult Intelligence Scale-Revised (WAIS-R), must be greater than 80.
- Medication status: No current use of any psychotropic medication or benzodiazepine.
- EXCLUSION CRITERIA:
- Because factors such as psychiatric disease, or CNS disease, can influence functional brain activity, these factors are exclusionary.
- Psychiatric history: Participants will be assessed using DSM-IV criteria via standardized psychiatric interviews conducted by trained examiners (i.e., SCID).
- Comparison individuals: All participants will be free of any current or past psychiatric disorder. Participants will be excluded if they meet criteria for substance dependence but not if they meet criteria for substance abuse.
- Individuals with psychopathy: It is to be expected that the individuals with psychopathy will meet diagnostic criteria for Antisocial Personality Disorder and, in childhood, would have met criteria for Conduct Disorder, Oppositional Defiant Disorder and probably Attentional Deficit and Hyperactivity Disorder. Any other current or past psychiatric disorder will be exclusory. Participants will be excluded if they meet criteria for substance dependence but not if they meet criteria for substance abuse.
- Severe acute and chronic medical illnesses. In short, any condition requiring the administration of systemic drugs will be exclusory.
- CNS disease: history of brain abnormalities (e.g., neoplasms, subarachnoid cysts), cerebrovascular disease, infectious disease (e.g., abscess), or other neurological disease, or history of head trauma (defined as loss of consciousness greater than 3 min).
- Metal or electronic objects: Metal plates, certain types of dental braces, cardiac pacemakers, etc., that are sensitive to electromagnetic fields contraindicate MRI scans.
- Claustrophobia: participants will be questioned about potential discomfort in being in an enclosed space, such as an MRI scanner.
- There will be no exclusion criteria as regards type of crime. While there is some increase in risk to testers in having participants who have committed acts of violence, it is not extreme as long as the participants are appropriately treated. Indeed, in our previous work almost all of our participants (comparison individuals and individuals with psychopathy) were murderers.
Exclusion
Key Trial Info
Start Date :
August 27 2004
Trial Type :
OBSERVATIONAL
End Date :
April 21 2008
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00352456
Start Date
August 27 2004
End Date
April 21 2008
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892